Wisconsin State Journal, 05.01.08
Tissue Regeneration Systems Inc., a medical device company developing bioactive implants for bone and soft tissue regeneration, on Thursday announced the close of a $2 million round of financing led by Madison-based Venture Investors and joined by the founders of TRS.
The company is a spin-out of the universities of Michigan and Wisconsin, where TRS' core proprietary technologies were developed over the past decade, and from which TRS has an exclusive option to commercialize.
Tissue Regeneration Systems Inc., a medical device company developing bioactive implants for bone and soft tissue regeneration, on Thursday announced the close of a $2 million round of financing led by Madison-based Venture Investors and joined by the founders of TRS.
The company is a spin-out of the universities of Michigan and Wisconsin, where TRS' core proprietary technologies were developed over the past decade, and from which TRS has an exclusive option to commercialize.